Antihyperalgesic effects of spinal cannabinoids

European Journal of Pharmacology

Volumn 345, Issue 2, 1998, Pages 145-153

  Richardson, Jennelle Durnett ^a   Aanonsen, Lin ^b   Hargreaves, Kenneth M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MACALESTER COLLEGE   (United States)

Author keywords

Cannabinoid; Capsaicin; Hyperalgesia; Spinal cord; Superfusion; Trigeminal ganglion

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID RECEPTOR; CAPSAICIN; CARRAGEENAN; OPIATE; POTASSIUM ION;

ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; MALE; MODULATION; NEUROSECRETION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; TRIGEMINUS GANGLION;

ANIMALS; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; CANNABINOIDS; CAPSAICIN; CARRAGEENAN; CYCLOHEXANOLS; INJECTIONS, SPINAL; MALE; MICE; PAIN THRESHOLD; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0032546267     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01621-X     Document Type: Article

References (28)

1. Aanonsen L., Richardson J.D., Nakkash R., Knoll J., Hargreaves K.M., Whitehead R. Characterization of carrageenan-induced hindpaw inflammation in the mouse. Abs. Soc. Neurosci. 22:1996;1808.
2. Aimone L.D., Yaksh T.L. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides. 10:1989;1127-1131.
3. 2+ current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106:1992;231-232.
4. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., Childers S.R. Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept. Channels. 1:1993;121-134.
5. Devane W.A., Dysarz F.A. III, Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
6. Dickenson, A.H., 1994. Where and how do opioids act? in: Gebhart, G.F., Hammond, D.L. (Eds.), Proceedings of the Seventh World Congress on Pain, IASP Press, Seattle, pp. 525-532.
7. Gamse R., Holzer P., Lembeck R. Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 308:1979;281-285.
8. Henry D.J., Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186:1995;91-94.
9. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
10. Holzer P. Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharm. Rev. 43:1991;143-201.
11. Hohmann A.G., Martin W.J., Tsou K., Walker J.M. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55, 212-2. Life Sci. 56:1995;2111-2118.
12. Howlett A.C. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci. 35:1984;1803-1810.
13. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
14. Hylden J.L.K., Thomas D.A., Iadarola M.J., Nahin R.L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194:1991;135-143.
15. Joris J., Costello A., Dubner R., Hargreaves K.M. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain. 43:1990;95-103.
16. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
17. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA. 89:1992;3825-3829.
18. Meyer, R.A., Campbell, J.N., Raja, S.N., 1994. Peripheral neural mechanisms of nociception. In: Wall, P.D., Melzack, R. (Eds.), Textbook of Pain. Churchill Livingstone, New York, pp. 13-44.
19. Mudge A.W., Leeman S.E., Fischbach G.D. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc. Natl. Acad. Sci. USA. 76:1979;526-530.
20. Perl, E.R., 1992. Alterations in the responsiveness of cutaneous nociceptors: Sensitization by noxious stimuli and the induction of adrenergic responsiveness by nerve injury. In: Willis, W.D. (Ed.), Hyperalgesia and Allodynia. Raven Press, New York, p. 59.
21. Richardson J.D., Aanonsen L., Hargreaves K.M. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol. 319:1997;R3-R4.
22. Richardson J.D., Aanonsen L., Hargreaves K.M. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18:1998;451-457.
23. 1 receptors. Pain. 75:1998;111-119.
24. Smith P.B., Compton D.R., Welch S.P., Razdan R.K., Mechoulam R., Martin B.R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:1994;219-227.
25. Stanfa L.C., Sullivan A.F., Dickenson A.H. Alterations in neuronal excitability and the potency of spinal μ-, δ- and κ-opioids after carrageenan-induced inflammation. Pain. 50:1992;345-354.
26. Stein, C., 1994. Interaction of immune-competent cells and nociceptors. In: Gebhart, G.F., Hammond, D.L. (Eds.), Proceedings of the Seventh World Congress on Pain, IASP Press, Seattle, p. 285.
27. Tsou K., Lowitz K.A., Hohmann A.G., Martin W.J., Hathaway C.B., Bereiter D.A., Walker J.M. Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience. 70:1996;791-798.
28. Willis, W.D., Coggeshall, R.E., 1991. Sensory Mechanisms of the Spinal Cord, Plenum, New York, NY.